{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T08:59:32Z","timestamp":1698569972263},"reference-count":22,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":5533,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1994,3]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Compliance with iron chelation therapy improves life expectancy in transfusion\u2010dependent haematological disorders. However, failure of compliance with parenteral desferrioxamine (DF) therapy and the expense incurred makes this drug unavailable for most patients in the developing world. We have been evaluating the orally active iron chelator 1,2\u2010dimethyl\u20103\u2010hydroxypyrid\u20104\u2010one (L<jats:sub>1<\/jats:sub>) in both preclinical and clinical trials. Five patients have developed reversible agranulocytosis during treatment with this agent. We have now studied the effects of L<jats:sub>1<\/jats:sub>, other \u03b1\u2010ketohydroxypyridines and DF on bone marrow myeloid progenitors using the CFU\u2010GM system. The results show that L<jats:sub>1<\/jats:sub> is less toxic than DF to normal bone marrow myeloid progenitors (ID<jats:sub>50<\/jats:sub>:130 \u03bcmol\/l versus 7.9 \u03bcmol\/l). The L<jats:sub>1<\/jats:sub> ID<jats:sub>50<\/jats:sub> is within the previously reported range of peak plasma values (80\u2013450 \u03bcmol\/l). When saturating concentrations of iron were added to the cultures, the mean toxicity of all the chelators was significantly decreased over the range of doses tested, e.g. L<jats:sub>1<\/jats:sub> ID<jats:sub>50<\/jats:sub>, 567 \u03bcmol\/l; DF ID<jats:sub>50<\/jats:sub>, &gt; 1000 \u03bcmol\/l. The toxicity of L<jats:sub>1<\/jats:sub> <jats:italic>in vitro<\/jats:italic> was similar for marrows from 3 normal donors and for the recovery marrow from a patient with thalassaemia major who had experienced agranulocytosis. Further studies are required to elucidate the mechanisms of L<jats:sub>1<\/jats:sub> \u2010induced agranulocytosis.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1994.tb01310.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T04:33:49Z","timestamp":1279427629000},"page":"176-179","source":"Crossref","is-referenced-by-count":17,"title":["Differential toxicity of \u03b1\u2010keto hydroxypyridine iron chelators and desferrioxamine to human haemopoietic precursors <i>in vitro<\/i>"],"prefix":"10.1111","volume":"52","author":[{"given":"J. M.","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. N.","family":"Al\u2010Refaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. N.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.V.","family":"Hoffbrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)90545-9"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.295.6612.1509"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb07887.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb07888.x"},{"issue":"1","key":"e_1_2_1_6_2","first-page":"3449","article-title":"Superior effectiveness of the oral iron chelator L1 Vs subcutaneous deferoxamine in patients with homozygous beta\u2010thalassaemia(HBT): the impact of patient compliance during two years of therapy","volume":"80","author":"Olivieri NF","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1182\/blood.V80.3.593.593","article-title":"Efficacy and possible adverse effects of the oral iron chelator 1,2\u2010dimethyl\u20103\u2010hydroxypyrid\u20104\u2010one (L1) in thalassaemia major","volume":"80","author":"Al\u2010refaie FN","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb06445.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90641-7"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000204494"},{"issue":"1","key":"e_1_2_1_11_2","first-page":"64","article-title":"The mechanism of agranulocytosis mediated by the oral iron chelator L1","volume":"83","author":"Veys PA","year":"1993","journal-title":"Br J Haematol"},{"key":"e_1_2_1_12_2","unstructured":"AgarwalMB GupteSS ViswanathanC VasandaniD DesaiN ChablaniAT.Long term efficacy and toxicity of L1\u2010oral iron chelator in transfusion dependent thalassemics over the last three years. Abstracts of the 5thInternational Conference on Thalassaemias and Haemoglobinopathies Nicosia Cyprus1993: p.192."},{"key":"e_1_2_1_13_2","first-page":"133","article-title":"Long term treatment of transfusion hemosiderosis with the oral iron chelator L1","volume":"28","author":"Goudsmit R","year":"1992","journal-title":"Drugs of Today"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood.V78.10.2727.2727","article-title":"Comparison of the subacute toxicity and efficacy of 3\u2010hydroxypyrid\u20104\u2010one iron chelators in overloaded and non overloaded mice","volume":"78","author":"Porter JB","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_15_2","first-page":"73","article-title":"Evidence of toxicity due to 1,2\u2010dimethyl\u20103\u2010hydroxypyrid\u20104\u2010one (L1) in normal rats","volume":"28","author":"Grady RW","year":"1992","journal-title":"Drugs of Today"},{"key":"e_1_2_1_16_2","unstructured":"ZervasJ KyriakouD KonstantopoulosK et al.Acute myelopathy after high dose desferrioxamine administration intravenously. Abstracts of the 3rd International Conference on Thalassaemia and Hemoglobinopthies Cagliari Italy.1989: p.167."},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-1693(00)85549-8"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V67.3.789.789","article-title":"Effect of acidic and basic isoferritin on in vitro growth of human granulocyte\u2010monocyte progenitors","volume":"667","author":"Dezza L","year":"1986","journal-title":"Blood"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.147"},{"key":"e_1_2_1_20_2","first-page":"104","article-title":"Effects of desferrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and vivo studies","volume":"3","author":"Dezza L","year":"1989","journal-title":"Leukemia"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1976.tb03570.x"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(88)80375-5"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198604033141402"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1994.tb01310.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1994.tb01310.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T01:04:49Z","timestamp":1698109489000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1994.tb01310.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1994,3]]}},"alternative-id":["10.1111\/j.1600-0609.1994.tb01310.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1994.tb01310.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,3]]}}}